Adhesion to the extracellular matrix is required for the expression and activation of the cyclin-cyclin-dependent kinase (CDK) complexes, and for G1 phase progression of non-transformed cells. However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the p27 cyclindependent kinase inhibitor (CKI), and the associated inhibition of cyclin E-CDK2. We now show that in epithelial cells the expression of c-Myc is tightly regulated by cell-substrate adhesion. When deprived of adhesion, two independently derived mammary epithelial cell lines, 184A1N4 and MCF-10A, rapidly decrease their level of c-Myc mRNA and protein. This decrease in levels of c-Myc correlates with G1 phase arrest, as indicated by hypophosphorylation of pRb and inhibition of the activity of the cyclin E-CDK2 complex. In 184A1N4 cells, cell-substrate adhesion is required for the suppression of p27, and induction of cyclin E, E2F-1, but not cyclins D1 and D3. Enforced expression of cMyc in non-adherent 184A1N4 and MCF-10A cells reverses the adhesion-dependent inhibition of cell cycle progression. Restoration of c-Myc in non-adherent cells induces the expression of E2F-1, and hyperphosphorylation of pRb in response to EGF treatment. In addition, expression of c-Myc results in the anchorage-independent activation of the CDK2 complex, the associated upregulation of cyclin E, and the destabilization and degradation of p27 by the ubiquitin-proteasome pathway. Our study thus suggests that c-Myc is the link between cell adhesion and the regulation of p27 and cyclin E-CDK2. Furthermore, we describe a role for c-Myc in adhesion-mediated regulation of E2F-1. Oncogene (2001) 20, 4554 ± 4567.
Introduction
To proliferate, normal cells require two types of extracellular signals: hormonal/growth factor stimuli and adhesion to the extracellular matrix (ECM). When deprived of attachment to a solid substrate, even in the presence of growth factors, normal cells are unable to replicate their DNA, and they arrest in the G1 phase of the cell cycle (Otsuka and Moskowitz, 1975; Matsuhisa and Mori, 1981; Guadagno and Assoian, 1991) . Recent studies have linked cell adhesion to key types of regulatory molecules required for the progression through the cell cycle: the cyclins and their associated cyclin-dependent kinases (CDK) (Zhu et al., 1996; Fang et al., 1996) .
Mitogenic stimulation of quiescent, adherent cells ®rst induces the expression the cyclin D family of proteins in mid-G1, which is followed by an increase in levels of cyclin E in late G1. Cyclins D1/2/3 and cyclin E associate with and activate CDK4/6 and CDK2, respectively (Sherr, 1995) . The cyclin D-CDK4/6 complexes and the cyclin E-CDK2 complex collaborate in the phosphorylation of the pRb family of proteins, triggering their release from the repressive pRb family-E2F transcriptional complex (Hatakeyama et al., 1994; Lundberg and Weinberg, 1998; Black and AzizkhanCliord, 1999) . Once Rb-free, the E2F complex transactivates the expression of cyclin E, cyclin A and a number of targets required for S phase progression and DNA replication Ohtani et al., 1995; Guo et al., 1998) . A common mechanism by which anti-mitogenic signals inhibit the activity of the cyclin-CDK complex, and thus block cell cycle progression, is through the induction of the cyclin dependent kinase inhibitors (CKI). Whereas the INK4 family of proteins speci®cally inhibits the cyclin D-CDK4 complex, the CIP/KIP inhibitors, which include p21, p27 and p57, are more ubiquitous. They associate both with the cyclin D-CDK4 complex and the cyclin E-CDK2 complex (Sherr and Roberts, 1999) .
In ®broblasts, loss of adhesion results in the down regulation of cyclin D Zhu et al., 1996) and cyclin A (Guadagno et al., 1993; Barrett et al., 1995; Shulze et al., 1996; Zhu et al., 1996) , as well as inhibition of the activity of the cyclin E-CDK2 complex, due to the accumulation of the CDK inhibitors, p21 and p27, and their association with the cyclin E-CDK2 complex (Fang et al., 1996; Zhu et al., 1996) . This inhibition of CDK activity prevents pRb phosphorylation, and arrests the cells in the G1 phase of the cell cycle.
Studies of the signaling pathways bridging cell adhesion to extracellular substrates to the cell cycle machinery, have concentrated, to date, on the regulation of expression of cyclin D. Speci®cally, they have highlighted the role of adhesion-dependent activation of the MAP kinase pathway in the induction of cyclin D1 (Roovers et al., 1999) . Furthermore, the cyclin D1 promoter is regulated by both the jun-fos (AP-1) and b-catenin-TCF transcription factors, and the expression and activation of these transcriptional complexes are regulated by cell-substrate adhesion-dependent pathways (Dike and Farmer, 1988; Dike and Ingber, 1996; Novak et al., 1998; Giancotti and Ruoslahti, 1999; Shtutman et al., 1999; Brown et al., 2000) , explaining the adhesion requirement for the expression of cyclin D. In contrast to cyclin D, the signaling pathway leading to CDK2 inhibition in non-adherent cells is largely unresolved, and the exact mechanism by which cell adhesion regulates the accumulation of cyclindependent kinase inhibitor, p27, remains to be elucidated.
A potential, but unexplored link between integrinmediated cell adhesion, enhanced expression of cyclins, and elevated activity of CDKs is the c-Myc early response gene. Experiments altering the expression of c-Myc indicate that expression of this proto-oncogene is required for cell proliferation, and plays a crucial role in progression through the G1 phase of the cell cycle (Heikkila et al., 1987; Eilers et al., 1991; Evan et al., 1992 , Hanson et al., 1994 . c-Myc induces cyclin E and cyclin A expression (Barrett et al., 1995; Steiner et al., 1995; Rudolph et al., 1996; Perez-Roger et al., 1997) , as well as the activity of the cyclin E-CDK2 complex, presumably by triggering the release of the kinase inhibitors p27 (Steiner et al., 1995; Vlach et al., 1996; Muller et al., 1997; Perez-Roger et al., 1997) , an eect strongly reminiscent of the one caused by cell adhesion in ®broblasts (Fang et al., 1996; Zhu et al., 1996) .
Possible signaling pathways regulating expression and function of c-Myc have been largely unexplored. The role of cell adhesion in the regulation of c-Myc itself is not well established. Studies examining c-Myc messenger RNA in ®broblasts have shown no immediate alteration in c-Myc mRNA levels when cells are deprived of adhesion Dike and Farmer, 1988) . A decrease in c-Myc mRNA could only be detected after 24 h of suspension culture of BALB/3T3 ®broblasts. However, adhesion may still play a role in the regulation of the transcription of cMyc in these cells; replating the cells, once they have downregulated c-Myc, induces an increase in c-Myc mRNA (Dike and Farmer, 1988) . In contrast, when placed in suspension culture, endothelial cells rapidly downregulate (within 1 h) c-Myc mRNA. These dierences in the regulation of c-Myc mRNA in response to adhesion may re¯ect various degrees of suppression of senescence of the model studied, or a cell-type speci®city of the eect. Therefore, the precise role(s) of cell adhesion on the regulation of c-Myc mRNA and protein need to be further explored.
Furthermore, the function of c-Myc in the anchorage-dependent regulation of the G1 checkpoint has not been studied. We have now examined the role of cell adhesion in EGF-dependent regulation of human mammary epithelial cell cycle progression, and investigated the role of c-Myc in mediating the adhesiondependent control of proliferation.
Our results indicates that human mammary epithelial cells respond to a disruption of cell-substrate adhesion by a profound decrease in the levels of c-Myc mRNA and protein. The G1 arrest under non-adherent conditions correlates with a decrease in the cellular levels of E2F-1, a decrease in the expression of cyclin E, and an inhibition of the cyclin E-CDK2 complex. Using both stable and transient transfection of c-Myc, we show that increased expression of c-Myc in nonadherent cells can revert the adhesion-dependent block at multiple points, allowing cells to progress through the G1/S transition. Enforced expression of c-Myc in non-adherent cells is sucient to allow anchorageindependent induction of E2F-1, and to promote the activation of the cyclin E-CDK2 complex, closely coupled to the increase in cyclin E and destabilization of p27. These results suggest that the decrease in the amount of c-Myc might be an important step in the adhesion-dependent G1 checkpoint of epithelial cells.
Results

Cell cycle distribution of non-adherent A1N4 and MCF-10A
To examine the role of cell adhesion in the regulation of cell cycle progression in human mammary epithelial cells, we ®rst analysed the cell cycle distribution of two immortalized mammary epithelial cell lines when deprived of adhesion, 184A1N4 (referred to hereafter as A1N4) and MCF-10A. Exponentially growing A1N4 and MCF-10A cells were trypsinized and maintained in suspension culture for 48 h. The DNA content of adherent and non-adherent cells was examined by¯ow cytometry after propidium iodine staining of their nuclei (Figure 1a) . In contrast to adherent cells, which were present in all the phases of the cell cycle, more than 80% of non-adherent A1N4 and MCF-10A contained 2N DNA, and 10 ± 15% of the cells 4N DNA. Less than 3% of the non-adherent cells had a DNA amount representative of S phase. These results show that, when deprived of adhesion, most of the cells arrest in G1, and that a minor population of cells arrests in G2/M. These observations suggest the presence of two adhesion-dependent regulation checkpoints, one in G1, and one in the G2 phase of the cell cycle. To further investigate the G1 phase adhesion-dependent checkpoint, we synchronized A1N4 cells in G0/G1 phase by EGF deprivation, and then restimulated the quiescent cells to enter the cell cycle by addition of 10 ng/ml of EGF (Figure 1b ) (Nass and Dickson, 1998) . Unlike their adherent counterparts, A1N4 cells stimulated with EGF in suspension culture were unable to progress into S phase and were blocked in G1 phase (Figure 1b) .
Regulation of the expression of c-Myc by cell adhesion
To investigate the hypothesis that c-Myc is a critical mediator in the anchorage-dependent G1 checkpoint, we ®rst examined the eect of cell adhesion on mitogen-dependent regulation of expression of c-Myc. Similar to the eect of serum in ®broblasts (Thompson et al., 1985) , exposure of adherent quiescent A1N4 cells to EGF induced a strong increase in the levels of cMyc protein within 1 h of stimulation (Figure 2a Figure  2b ). The level of the c-Myc protein started to increase within 2 h of cell adhesion, and by 4 h the expression of c-Myc reached a level comparable to that present in cells grown in monolayer. To ensure that the regulation of c-Myc by adhesion is not a particularity of the A1N4 cell line, we also tested another human mammary epithelial cell line, the MCF-10A ( Figure  2c ). When exponentially growing MCF-10A are deprived of adhesion, their level of c-Myc protein is decreased within 2 h, and c-Myc became undetectable by immunoblotting after 6 h of suspension culture.
We asked whether this decrease of c-Myc occurred at the mRNA level (Figure 2d ). The initial induction of Myc mRNA, following EGF stimulation, was similar in both adherent and non-adherent cells. However, after 4 h, a threefold decrease in the levels of mRNA was observed in suspension culture, as compared to adherent cells. These results suggest that cell adhesion is required for maximal, sustained expression of c-Myc in epithelial cells. Treatment of cells with cycloheximide reversed the decrease of cMyc mRNA in suspended cells, indicating that protein synthesis or a labile protein is required for down regulation of c-Myc mRNA. Furthermore, treatment of cells with Actinomycin D indicated that the decrease in c-Myc mRNA was not due to a decrease in its stability (data not shown). Therefore, these data suggest a transcriptional regulation of the c-myc gene by cell adhesion. However, we cannot exclude the presence of a post-transcriptional mode of regulation. These results indicate that cell adhesion is required both for the expression of c-Myc in cycling epithelial cells, and for the EGF-induced, sustained expression of c-Myc, when quiescent cells are stimulated to reenter the cell cycle.
c-Myc prevents early G1 arrest in non-adherent cells
To test whether this decrease in amount of c-Myc is responsible for the G1 phase block observed in nonadherent epithelial cells, we used A1N4 cells stably transfected with c-Myc under a constitutive promoter (A1N4-Myc cells) (Valverius et al., 1990) . In suspension culture, A1N4-Myc cells express between 2 to 4.5 times the levels of c-Myc present in adherent A1N4 cells (Figure 3) , indicating that the level of c-Myc restored in non-adherent cells is likely to be physiologically relevant. The ability of A1N4-Myc cells to progress through the G1 phase in suspension culture was assessed by the phosphorylation of the retinoblastoma protein (pRb) and the expression of the E2F-1 transcription factor ( Figure 4 ). As adherent cells progress through G1, pRb is progressively phosphorylated at multiple sites by the G1 cyclin-dependent kinases (Hatakeyama et al., 1994; Lundberg and Weinberg, 1998) . In early G1, pRb is present in its hypophosphorylated form, which can be separated by SDS ± PAGE from its hyperphosphorylated form, Figure 2 Regulation of c-Myc expression by cell adhesion in human mammary epithelial cells. (a) Quiescent A1N4 cells were stimulated to enter the cell cycle with EGF, either as a monolayer or in suspension. Cells were collected at the indicated times, following EGF stimulation. (b) A1N4 cells, maintained in suspension for 4 h in the presence of EGF, were transferred to tissue culture dishes, and were allowed to reattach for the indicated times. (c) Non-synchronized MCF-10A cells were refed fresh medium either as a monolayer (att) or in suspension (susp) for the indicated times. Whole cell lysates were prepared, and equal amounts of protein were resolved by SDS ± PAGE and analysed for levels of c-Myc by Western blotting (a ± c). (d) Quiescent A1N4 cells were stimulated with EGF as a monolayer or in suspension for the indicated times. Total RNA was analysed for c-Myc mRNA levels by Northern blot hybridization. Equal RNA loading was veri®ed using a probe for glyceraldehyde phosphate dehydrogenase (GAPDH) Figure 3 Expression of c-Myc in non-adherent A1N4-Myc cells. Quiescent A1N4 and A1N4-Myc cells were stimulated with EGF for 6 h and 15 h, either as a monolayer (A6, A15) or in suspension (S6, S15). Total cell lysates were analysed for levels of c-Myc by immunoblotting with a polyclonal c-Myc antibody characteristic of late G1 (Figure 4a ). In quiescent A1N4 cells, pRb is only detected in its hypophosphorylated, faster migrating form, which shifts to the hyperphosphorylated form, following EGF stimulation of cells grown in monolayer. In contrast, EGFstimulated, non-adherent cells failed to hypophosphorylate pRb, con®rming at the molecular level that nonadherent A1N4 cells are blocked in early G1. However, A1N4-Myc cells hyperphosphorylated pRb under nonadherent conditions, indicating that deregulated expression of c-Myc enables cells to override the adhesion-dependent, early G1 phase checkpoint.
Levels of E2F-1 can also be used as a marker of G1 phase progression, since the expression of this transcription factor is induced in mid to late G1 (Johnson et al., 1994; Black and Azizkhan-Cliord, 1999 ). The E2F-1 protein starts to be detectable within 6 h following EGF stimulation of quiescent, adherent A1N4 cells, and its level is markedly increased by 12 h, a time corresponding to the G1/S transition. Re¯ecting the G1 arrest, the expression of E2F-1 is not induced in non-adherent A1N4 cells. Adherent A1N4-Myc cells contain 2.5-fold higher levels of E2F-1 after 12 h of EGF stimulation. Although delayed, the expression of E2F-1 is rescued in non-adherent A1N4-Myc cells, where by 12 h it is expressed at levels comparable to adherent A1N4 cells (Figure 4b ). These observations support our pRb phosphorylation results, indicating that non-adherent cells expressing c-Myc progress through the adhesion-dependent G1 check point to the G1/S transition.
c-Myc is not required for the expression and activation of the cyclin D-CDK4 complexes
Since pRb is phosphorylated in non-adherent A1N4-Myc cells, we asked whether c-Myc is able to induce the expression and activity of the various G1 cyclin-CDK complexes in an adhesion-independent manner. We ®rst examined the cyclin D-CDK4 complexes ( Figure 5 ). The transcription of cyclin D1 is decreased in some ®broblasts deprived of adhesion, resulting in a decrease in cyclin-CDK4 activity (Zhu et al., 1996) . Northern blot analysis indicated that, although in suspension culture a lag period is required for EGFinduced upregulation of cyclin D1 mRNA, by 12 h equivalent levels of cyclin D1 transcripts could be detected in both adherent and non-adherent A1N4 cells (Figure 5a ). Similar kinetics in the induction of cyclin D1 mRNA were observed in A1N4-Myc cells, which expressed slightly higher levels of cyclin D1 mRNA (1.5-fold increase) than A1N4 cells (Figure 5a ). Western blot analysis for cyclin D3 showed an identical delay in the induction of cyclin D3 protein, caused by a lack of adhesion. Nevertheless, both A1N4 and A1N4-Myc cells expressed similar amount of cyclin D3, in an anchorage-independent manner (Figure 5b ). This observation, that non-adherent cells induce cyclin D1 and D3 in response to EGF, indicates that the adhesion-dependent checkpoint in A1N4 cells is in the early-mid G1 phase. The level of CDK4 protein was constant in both A1N4 and A1N4-Myc cells, regardless of whether they were quiescent, stimulated with EGF in monolayer, or in suspension (Figure 5b ). In addition, an in vitro kinase assay, where the cyclin D-CDK4 complex was immunoprecipitated with a CDK4 antibody and incubated with recombinant Rb protein as a substrate, indicated that the levels of CDK4 kinase activity were similar in non-adherent A1N4 and A1N4-Myc cells (Figure 5c ). Therefore, we concluded that cyclin D-CDK4 activity is still present in non-adherent A1N4 cells, and that overexpression of c-Myc does not alter the activity of the CDK4 complexes.
c-Myc prevents the inhibition of the cyclin E-CDk2 complex in non-adherent cells
We next examined the cyclin E-CDK2 complex ( Figure  6 ). To assess the activity of cyclin-dependent kinase 2 (CDK2), we immunoprecipitated CDK2 from total cell lysates. The kinase activity of these immunoprecipitates was tested by an in vitro kinase assay, using histone H1 as an exogenous substrate. Whereas lack of adhesion completely inhibited CDK2 kinase activity, overexpression of c-Myc in non-adherent cells restored CDK2 activity to levels similar to those detected in adherent cells (Figure 6a ). To explain these dierences in kinase activity between non-adherent A1N4 and A1N4-Myc cells, we examined by Western blotting the levels of positive and negative regulators of CDK2 present in total cell lysates. Unlike the parental cells, that only expressed very low level of cyclin E, A1N4-Myc cells induced cyclin E in suspension (Figure 6b ). In adherent, EGF-stimulated A1N4 cells, CDK2 migrates as a doublet on SDS ± PAGE. Others have reported that the faster migrating form correspond to molecules containing a stimulatory phosphorylation on threonine 160 (Gu et al., 1992; Fang et al., 1996) . Similarly to quiescent A1N4 cells, CDK2 was predominantly present in its slower migrating form in non-adherent A1N4 cells. However, the faster migrating form of CDK2 was strongly detectable in non-adherent A1N4-Myc cells (Figure 6b ), con®rming the dierence in CDK2 kinase activity observed in the in vitro kinase assay. This dierence in kinase activity could be explained, at least in part, by the dierence in the level of the CDK2 inhibitor, p27, which was signi®cantly decreased in the A1N4-Myc cells ( Figure  6b ). In contrast to the non-adherent A1N4 cells, where the total levels of p27 were strongly increased, no increase in p27 was detectable in the A1N4-Myc cells. Moreover, co-immunoprecipitation studies indicated that p27 is found complexed with CDK2, but not with CDK4 in non-adherent A1N4 cells (Figure 6c ). The amount of p27 associated with the CDK2 complex was decreased by 3 ± 4-fold in non-adherent A1N4-Myc P]ATP and recombinant Rb as an exogenous substrate. The in vitro kinase reaction was separated by SDS ± PAGE and the gel exposed to X-ray ®lm cells, where the CDK2 complex was mostly free of p27. The eect of both cellular adhesion and deregulated expression of c-Myc is speci®c to p27, since the levels of the CDK inhibitor p21 did not dier, comparing the two culture conditions (Figure 6b) . Together, the increased expression of cyclin E, the phosphorylation of CDK2, and the decreased association of p27 with the CDK2 complex may contribute to the induction of CDK2 activity in non-adherent A1N4-Myc cells.
c-Myc destabilizes the p27 CKI in non-adherent cells CDK2 kinase activity, observed in A1N4-Myc, cells is correlated with a decrease in the steady state level of the p27 protein. p27 is predominantly regulated at the post-transcriptional level, and the p27 protein has been shown to be rapidly degraded by the proteasomeubiquitin pathway Hengst and Reed, 1996) . To further investigate the mechanism by which the level of p27 are decreased in non-adherent A1N4-Myc cells, we ®rst compared the steady state levels of p27 mRNA between A1N4 and A1N4-Myc cells. Non-adherent A1N4-Myc cells showed no signi®cant decrease in total p27 mRNA (Figure 7a ). To determine whether the levels of p27 were regulated by a post-transcriptional mechanism, the stability of the p27 protein was examined by pulse-chase analysis (Figure 7b ). Non-adherent A1N4 and A1N4-Myc cells were labeled for 1 h with 35 S-methionine, and chased in non-radioactive medium for up to 180 min. Our results indicated that the half-life of p27 in suspended A1N4 cells was of about 100 min. In contrast, the half-life of p27 protein decreased to less than 35 min in A1N4-Myc cells. To examine whether the rapid degradation P]ATP and histone H1 as an exogenous substrate. The kinase reaction was separated by SDS ± PAGE and phosphorylated histone detected by radiography. (b) Total cell lysates were analysed by Western blotting for the levels cyclin E, CDK2, p27 and p21. CDK2 migrates on SDS ± PAGE as a doublet. (c) CDK2 and CDK4 complexes were immunoprecipitated from total cell lysates with anti-CDK2 and anti-CDK4 antibodies, respectively. The immunoprecipitates were frationated on SDS ± PAGE and the blot analysed by Western for the presence of p27. The blot was then reprobed with an anti-CDK2 antibody of the p27 protein observed in A1N4-Myc cells was caused by the ubiquitin-proteasome pathway, we treated A1N4-Myc cells, in suspension culture, with the proteasome inhibitor ALLN (Figure 7c ). Since the ALLN peptide aldehyde also inhibits calpains I and II, and cathepsin B and L, we also treated cells with a control peptide, ALLM, which has an equivalent inhibitory anity for calpains I and II, and cathepsin B and L, but has no eect on the proteasome. Incubation with the proteasome inhibitor ALLN speci®cally led to a threefold increase in the p27 protein, indicating that the proteasome-dependent degradation contributes to the decreased levels of p27 present in non-adherent A1N4-Myc cells.
Since the A1N4-Myc cells are stably transfected with the c-myc gene, we wished to ensure that the alteration S-methionine for 1 h, and chased with non-radioactive medium for the indicated times. p27 was immunoprecipitated from total cell lysate, the immunoprecipitate was fractionated on SDS ± PAGE, and radioactive p27 visualized by¯uorography (left panel). The signal intensity in the left panel was quanti®ed by densitometry and plotted against chase time. The signal intensity at time zero represents 100% (right panel). (c) A1N4-Myc cells were stimulated for 12 h in suspension with EGF alone or in the presence of the calpains and proteosome inhibitors ALLN, ALLM, or the DMSO vehicle. A1N4 cells stimulated with EGF for 12 h in suspension were used for comparison. Levels of p27 present in total cell lysate were determined by Western blot. (d) Exponentially growing MCF-10 cells were transiently transfected using a retrovirus carrying either PLXSN vector control or PLXSN carrying human c-Myc (PLXSN-MYC). Forty-eight hours after the infection, transfected, as well as non-transfected MCF10A were trypsinized and maintained in suspension in complete medium for the indicated times. Total cell lysates were analysed by Western blotting for the levels of c-Myc and p27
Oncogene Anchorage-dependent checkpoint and c-Myc CM Benaud and RB Dickson observed in the levels of p27 was a direct consequence of elevated levels of expression of c-Myc, and not due to selection in tissue culture. In addition, we wished to show that this eect of c-Myc on adhesion-dependent regulation of p27 is not a peculiarity of the A1N4 cell line. Therefore, we extended our study to the anchorage-dependent MCF-10A cells. We transiently transfected MCF-10A with the PLXSN retroviral construct carrying human c-myc under a constitutive promoter (Figure 7d ). When deprived of adhesion, MCF-10A cells increased their levels of p27 protein. This induction in the levels of p27 correlated with a decrease in c-Myc protein (Figures 2 and 7d) , and with G1 arrest (Figure 1) . Expression by retroviral infection of c-Myc in MCF-10A cells was sucient to prevent the increase in the levels of p27 under non-adherent culture conditions (Figure 7d ). Similar to the noninfected MCF-10A cells, the level of p27 was increased in non-adherent control cells infected with retrovirus carrying the PLXSN vector alone.
Discussion
Although c-Myc is known to be critical for the progression of the G1/S phase of the cell cycle, particularly in response to growth factor stimuli, its role is unclear in the regulation of cell cycle progression in response to cell-substrate adhesion. In this report, we analyse the role of c-Myc in the anchorage-dependent G1 checkpoint in human mammary epithelial cells (Figure 8 ). We show that the expression of c-Myc is tightly regulated by cell adhesion in human mammary epithelial cells. In nonadherent cells the decrease in the levels of c-Myc correlates with G1 cell cycle arrest. However, restoration of the expression of c-Myc in non-adherent epithelial cells allows these cells to bypass the adhesion requirement for the expression and activation of key targets at the G1/S transition. Expression of c-Myc in non-adherent cells prevents the stabilization of p27, restores the expression of cyclin E, and thereby results in the adhesion-independent activation of the CDK2 complex and the hyperphosphorylation of pRb. In addition, the expression of c-Myc in non-adherent cells rescues the expression of E2F-1 in response to the EGF stimuli. Taken together, these results suggest that cMyc mediates the adhesion-dependent regulation of the cyclin E-CDK2, complex and of the E2F-1 transcription factor.
Previous reports have shown considerable variation, based on the model used, on the eect of cell adhesion on the expression of c-Myc mRNA. We found that cell adhesion is not necessary for the initial, immediate induction of c-Myc by EGF. Rather, cell adhesion is required for the sustained expression of c-Myc in cycling cells. In the absence of adhesion, A1N4 and MCF-10A epithelial cells rapidly decrease their levels of c-Myc, contrasting with reports in BALB/3T3 cells, and in primary cultures of human skin ®broblasts (Dike and Farmer, 1988; Bohmer et al., 1996) . Cell adhesion in mammary epithelial cells regulates the expression of c-Myc, at least in part, at the level of transcription, since a threefold decrease in Myc mRNA is observed in non-adherent cells. This decrease in cMyc cannot be accounted for by a decrease in its mRNA stability. However, an additional post-transcriptional mechanism of regulation might play a role, since the decrease in the c-Myc protein is greater than the one observed at the level of c-Myc mRNA. c-Myc can be regulated both at the levels of translation initiation and of protein stability (Spencer and Groudine, 1991; Flinn et al., 1998; Salghetti et al., 1999) . It is tempting to speculate that adhesion may alter the stability of c-Myc, since c-Ras can stabilize cMyc (Sears et al., 1999) , and since signaling by c-Ras is adhesion-dependent (Lin et al., 1997; Howe and Juliano, 1998) .
To address whether regulation of c-Myc is required for the adhesion-dependent checkpoint, we compared A1N4 cells with stably transfected A1N4-Myc cells, which constitutively express murine c-Myc. Enforced expression of c-Myc in non-adherent cells is sucient to restore pRb phosphorylation. Both the cyclin D-CDK4 complex and the cyclin E-CDK2 complex participate in the phosphorylation of pRb (Hatakeyama et al., 1994; Lundberg and Weinberg, 1998) , and their expression and activity is regulated by cell adhesion (Fang et al., 1996; Zhu et al., 1996) . The transcription of cyclin D1 is regulated by cell adhesion in some ®broblast systems (Zhu et al., 1996) , but not others (Fang et al., 1996; Shulze et al., 1996) . In our human mammary epithelial A1N4 cells, the induction of cyclin D1 mRNA is growth factor-dependent, but adhesion-independent. Although cell adhesion is not necessary for the induction of cyclin D1, it alters the kinetics of accumulation of cyclin D1. The peak expression of cyclin D1, following EGF stimulation, is delayed by 6 h in cells maintained in suspension, as compared to those in monolayer. This induction of cyclin D1 indicates that non-adherent A1N4 cells are still responsive to EGF, and are able to progress through mid-G1 phase in an anchorage-independent manner. In addition to the expression of cyclins D1 and D3, two other lines of evidence indicate that the cyclin D-CDK4 complex is not mediating the anchorage-dependent control of G1 phase progression, nor is this complex a target of c-Myc. First, the levels of the CDK4 inhibitor p16 are low in the A1N4, and remain unaected by either adhesion or c-Myc (data not shown). Furthermore, the CDK4 complex is active in non-adherent A1N4 cells, and this activity is not altered by c-Myc.
In contrast, we found that cell adhesion is strictly required for the activation of CDK2 in A1N4, and expression of c-Myc can reverse that eect. Our results suggest that the ability of c-Myc to rescue the activity of CDK2 in non-adherent cells is mediated through at least two steps. First, the amount of the positive regulator of CDK2, cyclin E, is increased. Second, the level of the CDK2 inhibitor, p27, is decreased. In contrast to ®broblasts which induce cyclin E under non-adherent conditions (Carstens et al., 1996; Fang et al., 1996; Shulze et al., 1996; Zhu et al., 1996) , the expression of cyclin E is adhesiondependent in the A1N4 cells. Expression of c-Myc in suspended cells is sucient to restore the amount of cyclin E to a level similar to the one present in adherent cells. Consequently, increased availability of cyclin E may allow its association and activation CDK2. Deregulated expression of c-Myc results in an increase in the level of cyclin E under nonproliferative conditions, such as serum starvation and con¯uence arrest (Jansen-Durr et al., 1993; Steiner et al., 1995) , where the levels of cyclin E are normally very low. In contrast, c-Myc does not aect the level of cyclin E in exponentially growing cells (Jansen-Durr et al., 1993) . Similarly, upon EGF stimulation, adherent A1N4 and A1N4-Myc cells do not display any signi®cant dierence in the induction of cyclin E. However, expression of c-Myc in nonadherent cells promotes the expression of cyclin E. This dierence in the eect of c-Myc, based on the proliferative status of the cells, suggests that c-Myc may play a role in the de-repression of cyclin E, rather than its direct induction. The ability of c-Myc to relieve transcriptional repression has recently been described for the cyclin D2 gene (Bouchard et al., 1999) . Alternatively, the transcription of cyclin E in non-adherent cells may be driven by E2F-1, whose expression is rescued in A1N4-Myc cells. The cyclin E promoter contains an E2F binding site, and E2F-1 overexpression increases the level of cyclin E Ohtani et al., 1995) . Our current data do not indicate whether the expression of E2F-1 precedes the expression of cyclin E. However, the 2.5-fold increase in levels of E2F-1 detected in adherent A1N4-Myc cells does not result in an increase in the levels of cyclin E, suggesting that E2F-1 alone may not be implicated in the regulation of cyclin E by cMyc.
In addition to the decrease in cyclin E, the increase in the levels of the CDK inhibitor, p27, participates in the inhibition of the CDK2 complex in non-adherent cells. Similar to previous reports, the absence of adhesion results in a 3 ± 4-fold increase in association of p27 with CDK2. This magnitude of increased binding of p27 to CDK2 has been reported to be sucient to inhibit CDK2 (Harper et al., 1995) . Expression of c-Myc in non-adherent cells decreases the levels of p27 associated with CDK2 to levels similar to those observed in adherent, proliferating A1N4 cells. c-Myc is believed to indirectly induce the activation of the cyclin E ± CDK2 complex by inducing the transient interaction of p27 with a`heat labile' protein, and thus, displacing p27 from the CDK2 complex (Steiner et al., 1995; Vlach et al., 1996; Muller et al., 1997; PerezRoger et al., 1997) . Two mechanisms have been proposed to drive the release of p27 from the CDK2 complex. First, a c-Myc-dependent increase in cyclin D1 and D2 may titer p27, displacing this CKI from the cyclin E ± CDK2 complex to the cyclin D ± CDK4 complex (Bouchard et al., 1999; Perez-Roger et al., 1999) . However, in other models, cyclin D expression is not altered by c-Myc, and is not required for the activation of cyclin E ± CDK2 complex. Nevertheless, c-Myc induces the dissociation of CDK2-phosphorylated p27 from the cyclin E ± CDK2 complex. Although not required for c-Myc-dependent activation of cyclin E ± CDK2 complex, the phosphorylation and release of p27 from the CDK2 complex is believed to be the ®rst step for targeting of p27 for degradation through the ubiquitin-proteosome pathway  Muller et al., 1997; Perez-Roger et al., 1997). Even though the A1N4-Myc cells express a slightly higher level of cyclin D1 mRNA than the parental A1N4 cells, this does not in¯uence the distribution of p27. We could not detect any p27 associated with CDK4 by coimmunoprecipitation, even though we could detect the association of p27 with a minor population of the CDK2 complexes in non-adherent A1N4-Myc cells. Therefore, c-Myc appears to induce the release of p27 from the CDK2 complex, which leads to its degradation through the ubiquitin-proteasome pathway, rather than its displacement from the CDK2 complex to the CDK4 complex. In agreement with this hypothesis, the stability of p27 is sharply decreased in non-adherent A1N4-Myc cells. In addition, treatment of nonadherent A1N4-Myc cells with a proteasome inhibitor results in a threefold increase in p27. In A1N4, c-Myc speci®cally regulates the levels of p27. The level of another member of the same family of CDK inhibitors, p21, was not altered by adhesion or c-Myc. We were unable to assess the eect of adhesion and c-Myc on the third member of this CDK family, p57, since A1N4 cells do not express this CKI (Nijjar et al., 1999) .
In both A1N4 and MCF-10A cells, the expression of c-Myc and of p27 are inversely correlated. Extracellular, anti-mitogenic signals also elicit a similar pattern. TGF-b-induced growth arrest of epithelial and endothelial cells, and growth inhibition due to cell ± cell contact, each of which are believed to be mediated by the induction of p27, also result in the decrease of cMyc levels (Sejersen et al., 1985; Kumatori et al., 1991; Polyak et al., 1994; Alexandrow and Moses, 1995) . Mutual exclusion of c-Myc and p27 expression, in addition to the ability of c-Myc to decrease the level of p27, suggests that a decrease in levels of c-Myc is a general mechanism whereby anti-mitogenic signals induce p27 stabilization and cell cycle arrest.
Ectopic expression of c-Myc has been reported to rescue the expression of cyclin A in non-adherent Rat1 ®broblasts (Barrett et al., 1995) . We have made a similar observation in the A1N4 cells. Expression of cyclin A is adhesion-dependent, and deregulated expression of c-Myc can induce the expression of cyclin A in non-adherent A1N4 epithelial cells (data not shown). The results presented in this report suggest a mechanism whereby c-Myc in¯uences the expression of cyclin A in non-adherent cells. Repression of the transcription of cyclin A in non-adherent cells is mediated by the E2F binding site in the cyclin A promoter (Shulze et al., 1996) . Serum stimulation of quiescent cells results in a switch from the transactivation-repressive, E2F-p107 complex to free E2F and the E2F-p107-cyclin E complex under adherent conditions. In contrast, in non-adherent cells, this switch does not occur, thereby maintaining the inhibition of cyclin A transcription. In addition, p27 prevents the activation of the cyclin A promoter by blocking the association of cyclin E-CDK2 with the E2F-p107 complex (ZerfassThome et al., 1997) . Therefore, the decrease in the levels of p27, the increase in the levels of cyclin E, the activation of CDK2, and the phosphorylation of members of the Rb family of proteins by c-Myc may all be implicated in the regulation of transcription of the cyclin A gene. Furthermore, enforced expression of c-Myc in non-adherent cells rescues the expression of E2F-1. This c-Myc-dependent induction of E2F could provide free E2F to drive the transcription of cyclin A. These data are consistent with our recent observation of c-Myc-associated expression of E2F-1 and cyclin A in transgenic mouse mammary tumorigenesis in vivo studies (Liao et al., 2000) .
How c-Myc participates in the induction of E2F-1 is not clear. E2F-2, an E2F family member which has a cell cycle-dependent pattern of expression similar to E2F-1, has been proposed to be a direct target of cMyc, based on the ®nding that the E2F-2 gene contains a c-Myc-responsive E box in its promoter (Sears et al., 1997) . However, no c-Myc-binding element has yet been identi®ed in the E2F-1 promoter. Alternatively, cMyc could induce the expression of E2F-1 through the inactivation of the Rb family of pocket proteins. In quiescent cells, the transcription of E2F-1 is repressed by the binding of the Rb family-E2F complexes to the E2F binding site in the E2F-1 promoter (Black and Azizkhan-Cliord, 1999) . This repression may not be released when cells are stimulated with EGF in suspension, thereby preventing the expression of E2F-1 that is normally observed in adherent cells late in G1. In response to EGF, phosphorylation of pRb in nonadherent, c-Myc-transfected cells may release the transcriptional repression of the E2F-1 gene, and allow for anchorage-independent expression of E2F-1. Our data indicate that non-adherent cells are still responsive to EGF, and that EGF is required for c-Myc-induced G1 phase progression in these cells.
Not only do cyclin E-CDK2 and E2F reciprocally in¯uence the expression and activity of each other, but they also collaborate in the induction of S phase and of DNA replication . Our results show that both cyclin E-CDK2 and E2F-1 are regulated by cell adhesion in epithelial cells. Furthermore, c-Myc can bypass the adhesion control of G1/S phase transition at multiple points by restoring the activity of cyclin E-CDK2, as well as the expression of E2F-1. Thus, a decrease in the level of c-Myc in non-adherent cells is likely to be a critical event to prevent anchorage-independent progression into S phase.
Materials and methods
Cell culture and flow cytometry
184A1N4 is a non-tumorigenic cell line derived from a primary culture of human mammary epithelial cells that were immortalized with benzo(a)pyrene (provided by Dr MR Stampfer, University of California, Berkeley, CA, USA) (Stampfer and Bartley, 1985) . These cells were then transformed with a retroviral expression vector containing the mouse c-Myc oncogene, giving rise to the stably transfected 184A1N4-Myc cell line, which overexpresses the Myc protein (provided by Dr D Salomon, NCI, NIH, USA) (Valverius et al., 1990) . Cells were plated at low density (6.6610 3 cells/cm 2 ) and allowed to adhere in complete medium, IMEM (Gibco ± BRL, Rockville, MD, USA), supplemented with 0.5% fetal bovine serum (Gibco ± BRL), 0.5 mg/ml hydrocortisone (Sigma, St Louis, MO, USA), 5 mg/ ml insulin (Bio¯uids, Rockville, MD, USA) and 10 ng/ml epidermal growth factor (EGF) (Collaborative Biomedical Research, Waltham, MA, USA) for 5 ± 7 h. Cells were then washed twice with phosphate buered saline (PBS), and maintained in a low serum, EGF-free medium (IMEM (Gibco ± BRL), supplemented with 0.5% fetal bovine serum (Gibco ± BRL), 0.5 mg/ml hydrocortisone (Sigma), 5 mg/ml insulin (Bio¯uids)) for 48 ± 72 h to synchronize the cells in G0/G1 (Stampfer et al., 1993) . Quiescent cells were then subjected to stimulation by EGF (10 ng/ml), either in suspension or in monolayer cultures. A second nontumorgenic, mammary epithelial line, MCF-10A (Michigan Cancer Foundation) (Soule et al., 1990) was maintained in 50 : 50% IMEM:HAM F12 (Gibco ± BRL) supplemented with 5% horse serum, 0.5 mg/ml hydrocortisone (Sigma), 5 mg/ml insulin (Bio¯uids) and 10 ng/ml EGF. For suspension culture, cells were trypsinized and transferred to agarose-coated dishes. To prevent cell adhesion, tissue culture dishes were coated with boiling 0.8% agarose (5 ml/100 mm dishes; 10 ml/150 mm dishes). The agarose was then equilibrated overnight with an equal volume of medium.
For cell cycle studies, cells were collected, ®xed in citrate buer/DMSO, and their nuclei stained with propidium iodine (Vindelov et al., 1983) . The DNA content was analysed bȳ ow cytometry (Lombardi Cancer Center Flow Cytometry Core). Cycloheximide and Actinomycin D were purchased from Sigma; ALLM and ALLN from Calbiochem (La Jolla, CA, USA).
Retroviral transfection
The PLXSN retroviral vector and the PLXSN vector containing the cDNA encoding the human c-Myc (PLXSN ± MYC) (provided by Dr MR Stampfer) were transfected into GP+E86 cells by calcium phosphate, followed by glycerol shock. The next day the packaging cells expressing the PLXN or the PLXSN ± MYC ecotropic viruses were changed to selection medium containing 600 mg/ml G418 (Mediatech, Inc., Herndon, VA, USA). When the cells became con¯uent, the virus-containing supernatant was collected and used to infect PA317 amphotropic packaging cells (ATCC, Rockville, MD, USA). Following infection, PA317 cells producing PLXSN and PLXSN ± Myc retroviruses were selected in the presence of 500 mg/ml G418. PA317 cells producing high titers of retroviruses were subcloned.
For transient transfection of MCF-10A, 2610 5 cells in 100 mm dishes were infected with 5 ml of supernatant containing a high titer of either PLXSN or PLXSN ± MYC retrovirus, supplemented by 8 mg/ml polybrene (Sigma). After 2 h 378C, 5 ml of MCF-10A growth medium containing 8 mg/ml polybrenene was added to the cells. The next day, the supernatant was removed from the cells, and the cells were fed with MCF-10A growth medium. Cells were trypsinized 48 h following infection, and transferred to suspension plates.
Western blotting
For preparations of whole cell extracts, adherent cells were scraped in PBS, and non-adherent cells collected and pelleted by centrifugation (1500 g). The cell pellets were lysed on ice in lysis buer (1% Triton X-100, 50 mM Tris, pH 8.0, 150 mM NaCl, 1 mM EDTA, 50 mM sodium¯uoride, 0.5 mM sodium orthovanadate, 60 mg/ml aprotinin, 10 mg/ ml leupeptin, 1 mg/ml pepstatin, 10 mg/ml PMSF). Cellular debris were removed by centrifugation for 10 min at 14 000 g. Equal amounts of proteins, as determined by the BCA protein micro assay (Pierce, Rockford, IL, USA), were resolved by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS ± PAGE), and electroblotted onto PVDF membranes (Millipore, Bedford, MA, USA). For immunoblotting, membranes were blocked in PBS-0.1% Tween 20 with 5% milk overnight at 48C. The blots were then incubated with the primary antibody for 1 h at room temperature, followed by a 1 h incubation with either a 1 : 10 000 dilution goat anti-mouse secondary antibody conjugated with horseradish peroxidase (Biorad, Hercules, CA, USA), or a 1 : 5000 dilution of anti-rabbit HRP-linked secondary antibody (Amersham, Arlington Heights, IL, USA). Immunoreactive proteins were detected with chemiluminescent substrate (Pierce). Equal protein loading was con®rmed by staining the membrane with 1% amino black. The following antibodies were used: monoclonal 9E10 antihuman c-Myc, anti-pRb (G3-245) and anti-p21 (6B6) from Pharmingen (San Diego, CA, USA), polyclonal anti-c-Myc (C-19), anti-CDK2 (M2), anti-CDK4 (C-22), anti-cyclin D3 (C-16), and anti-E2F-1 (C-20) from Santa Cruz (Santa Cruz, CA, USA), anti-p27Kip1 from Transduction Laboratories (Lexington, KY, USA), and anti-cyclin E from UBI (Lake Placid, NY, USA).
Northern blotting
To prepare total cellular RNA, 10 6 cells were collected and resuspended in 2 ml of Rnazol (Tel-test, Inc., Friendswood, TX, USA). The RNA was prepared according to the manufacturer's instructions. 10 mg of total RNA was separated on 1% agarose-formaldehyde gels and transferred onto N-Hybond nylon membranes (Amersham). Blots were cross linked by UV light exposure (UV stratalinker, Stratagene, La Jolla, CA, USA) and prehybridized in 50% formaldehyde, 56SSPE, 56Denhardt, 0.5% SDS, and 0.2 mg/ml heat denatured salmon sperm DNA at 428C for 6 h. Cyclin D1 and p27 mRNA expression were detected using randomly primed radiolabeled probes (Pharmacia, Piscataway, NJ, USA) generated from cyclin D1 and p27 cDNA (gifts from Dr S Reed, Scripp, San Diego, CA, USA). Probes were heat denatured, added to the pre-hybridization solution, and hybridized overnight at 428C. Blots were reprobed for GAPDH as loading control.
In vitro kinase assay CDK2 and CDK4 were immunoprecipitated overnight at 48C from 100 mg of total cell lysates proteins with anti-CDK2 (M2) and anti-CDK4 (C-22) antibodies, respectively. The antibodies were collected with 40 ml of 50% protein A sepharose (Pharmacia) for 1 h at 48C. The immunoprecipitates were washed three times in lysis buer, followed by two washes in kinase buer (50 mM TrisHCl pH 7.5, 10 mM MgCl 2 , 1 mM DTT), and then resuspended in 30 ml of kinase buer. The samples were incubated at 308C for 15 ± 30 min with 20 mM ATP, 5 ± 10 mCi [ 32 g]ATP (3000 Ci/mmol, Amersham), and 1 mg Histone H1 (Sigma) as a substrate for CDK2, or 1 mg recombinant pRb (pRb769 from Santa Cruz, Inc) as a substrate for CDK4. The kinase reaction was stopped by addition of 26loading buer. After boiling, the kinase reactions were separated on a 10% SDS ± PAGE, the gel dried, and the phosphorylated substrates detected by autoradiography.
Pulse-chase analysis 1.5610 6 quiescent cells were stimulated with 10 ng/ml of EGF in suspension for 4 h. Cells were then deprived of methionine for 20 min, pulse labeled in suspension for 1 h with 125 mCi 35 S-methionine (NEN, Boston, MA, USA), washed once with PBS, and then chased for up to 3 h in non-radioactive, complete medium. Cells were lysed and protein concentration quanti®ed with BCA reagent (Pierce). p27 was immunoprecipitated from 150 mg total cell extracts using p27 polyclonal antibody (C19) from Santa Cruz Inc, overnight at 48C overnight. The immunoprecipitate was collected with protein A sepharose and washed ®ve times with lysis buer. Immunoprecipitates were separated on SDS ± PAGE and labeled proteins visualized by¯uorogra-phy. For densitometry analysis exposed X-ray ®lms were scanned using DNA35 scanner (PDI/Biorad) and the image analysed with the ImageQuant software from Molecular Dynamics.
